Acceptability of human papillomavirus vaccination among academics at the University of KwaZulu-Natal, South Africa

References

• Forman D, de Martel C, Lacey CJ, et al. Global Burden of Human Papillomavirus and Related Diseases. Vaccine. 2012;30:F12–23.10.1016/j.vaccine.2012.07.055
   PubMed Web of Science ®Google Scholar
• Centre for Disease Control and Prevention. 2010 [cited 2014 Sep 24]. Available from: http://www.cdc.gov/hpv/.
   Google Scholar
• Chan PKS, Ho WCS, Wong MC, et al. Epidemiologic risk profile of infection with different groups of human papillomaviruses. J Med Virol. 2009;81:635–44.
   Google Scholar
• Bruni L, Barrionuevo-Rosas L, Albero G, et al. ICO information centre on HPV and cancer (HPV information centre). Human Papillomavirus and Related Diseases in South Africa, 2014. Summary Report 2014-12-18. 2014 [cited 2015 Jan 15]. Available from: http://www.who.int/hpvcentre.
   Google Scholar
• Smith JS, Lindsay L, Hoots B, et al. Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical lesions: a meta-analysis update. Int J Cancer. 2007;121(3):621–32.10.1002/(ISSN)1097-0215
   PubMed Web of Science ®Google Scholar
• Giuliano AR, Palefsky JM, Goldstone S, et al. Efficacy of quadrivalent HPV vaccine against HPV infection and disease in males. N Engl J Med. 2011;364(5):401–11.10.1056/NEJMoa0909537
   PubMed Web of Science ®Google Scholar
• Lu B, Kumar A, Castellsagué X, et al. Efficacy and safety of prophylactic vaccines against cervical hpv infection and diseases among women: a systematic review & meta-analysis. BMC Infect Dis. 2011;11:13.10.1186/1471-2334-11-13
   PubMed Web of Science ®Google Scholar
• Palefsky JM, Giuliano AR, Goldstone S, et al. HPV vaccine against anal HPV infection and anal intraepithelial neoplasia. N Engl J Med. 2011;365(17):1576–85.10.1056/NEJMoa1010971
   PubMed Web of Science ®Google Scholar
• US Department of Health and Human Services. Healthy people 2020. 2010 [cited 2014 Oct 17]. Available from: www.healthypeople.gov/2020/topicsobjectives2020/objectiveslist.aspx?topicId=23.
   Google Scholar
• Markowitz LE, Tsu V, Deeks SL, et al. Human papillomavirus vaccine introduction—the first five years. Vaccine. 2012;30(5):F139–48.10.1016/j.vaccine.2012.05.039
   Google Scholar
• Moodley I, Tathiah N, Mubaiwa V, et al. High uptake of Gardasil vaccine among 9–12-year-old schoolgirls participating in an HPV vaccination demonstration project in KwaZulu-Natal, South Africa. S Afr Med J. 2013;103:313–7.
   PubMed Web of Science ®Google Scholar
• Basu P, Mittal S. Acceptability of human papillomavirus vaccine among the urban, affluent and educated parents of young girls residing in Kolkata, Eastern India. J Obstet Gynaecol Res. 2011;37(5):393–401.10.1111/jog.2011.37.issue-5
   PubMed Web of Science ®Google Scholar
• Hoque ME, Van Hal G. Acceptability of human papillomavirus vaccine: a survey among Master of Business Administration students in KwaZulu-Natal, South Africa. Biomed Res Int. 2014:257807. doi: 10.1155/2014/257807.
   PubMed Web of Science ®Google Scholar
• Chang IJ, Huang R, He W, et al. Effect of an educational intervention on HPV knowledge and vaccine attitudes among urban employed women and female undergraduate students in China: a cross-sectional study. BMC Pub Health. 2013;13:916.10.1186/1471-2458-13-916
   PubMed Web of Science ®Google Scholar
• South African Department of Health. Expanded programme on immunisation — EPI (SA) revised childhood immunisation schedule from April 2009. [cited 2015 Jan 23]. Available from: http://www.kznhealth.gov.za/vaccinations.pdf.
   Google Scholar
• Health Systems Trust. The district health barometer 2008/09. Part A: indicator comparison by districts. output indicators: immunisation. 2010 [cited 2015 Feb 5]. Available from: http://www.hst.org.za/sites/default/files/dhb080931.pdf.
   Google Scholar
• Burnett RJ, Larson HJ, Moloi MH, et al. Addressing public questioning and concerns about vaccination in South Africa: A guide for healthcare workers. Vaccine. 2012;30:C72–8.10.1016/j.vaccine.2012.03.037
   PubMed Web of Science ®Google Scholar
• Crowcroft NS, McKenzie KJ. Inoculating communities against vaccine scare stories. Lancet Infect Dis. 2013;13:564–5.10.1016/S1473-3099(13)70131-2
   PubMed Web of Science ®Google Scholar
• Ezeanochie MC, Olagbuji BN. Human papilloma virus vaccine: determinants of acceptability by mothers for adolescents in Nigeria. Afr J Reprod Health. 2014;18(3):154–8.
   Web of Science ®Google Scholar
• Perlman S, Wamai RG, Bain PA, et al. Knowledge and awareness of HPV vaccine and acceptability to vaccinate in Sub-Saharan Africa: a systematic review. PLoS ONE. 2014;9(3):e90912. doi:10.1371/journal.pone.0090912.
   PubMed Web of Science ®Google Scholar
• Reiter PL, Stubbs B, Panozzo CA, et al. HPV and HPV vaccine education intervention: effects on parents, healthcare staff, and school staff. Cancer Epidemiol Biomarkers Prev. 2011;20(11):2354–61.10.1158/1055-9965.EPI-11-0562
   PubMed Web of Science ®Google Scholar
• Hopfer S. Effects of a narrative HPV vaccination intervention aimed at reaching college women: a randomized controlled trial. Prev Sci. 2012;13:173–82.10.1007/s11121-011-0254-1
   PubMed Web of Science ®Google Scholar
• Ports KA, Reddy DM, Rameshbabu A. Barriers and facilitators to HPV vaccination: perspectives from malawian women. Women Health. 2013;53(6):630–45.10.1080/03630242.2013.809046
   PubMed Web of Science ®Google Scholar
• Remes P, Selestine V, Changalucha J, et al. A qualitative study of HPV vaccine acceptability among health workers, teachers, parents, female pupils, and religious leaders in northwest Tanzania. Vaccine. 2012;30(36):5363–7.10.1016/j.vaccine.2012.06.025
   PubMed Web of Science ®Google Scholar
• Markowitz LE, Dunne EF, Saraiya M, et al. Quadrivalent human papillomavirus vaccine: recommendations of the advisory committee on immunization practices (ACIP). MMWR Recomm Rep. 2007;56(RR-2):1–24.
   PubMedGoogle Scholar
• Centre for Disease Control and Prevention. National and state vaccination coverage among adolescents aged 13-17 years — United States, 2012. MMWR Morb Mortal Wkly Rep. 2013;62(34):685–93.
   PubMed Web of Science ®Google Scholar
• Hofstetter AM, Stockwell MS, Al-Husayni N, et al. HPV vaccination: are we initiating too late? Vaccine. 2014;32(17):1939–45.10.1016/j.vaccine.2014.01.084
   PubMed Web of Science ®Google Scholar
• Smith PJ, Humiston SG, Marcuse EK, et al. Parental delay or refusal of vaccine doses, childhood vaccination coverage at 24 months of age, and the health belief model. Public Health Rep. 2011;126(2):135–46.
   PubMed Web of Science ®Google Scholar
• Harries J, Moodley J, Barone MA, et al. Preparing for HPV vaccination in South Africa: key challenges and opinions. Vaccine. 2009;27(1):38–44.10.1016/j.vaccine.2008.10.033
   PubMed Web of Science ®Google Scholar
• Coleman MA, Levison J, Sangi-Haghpeykar H. HPV vaccine acceptability in Ghana, West Africa. Vaccine. 2011;29(23):3945–50.10.1016/j.vaccine.2011.03.093
   PubMed Web of Science ®Google Scholar